| RGLS Stock Yearly Return 2019 Table | ||||||||||||||||||||||||||||||
RGLS average annual return is presented with the assumption of reinvestments of any dividends on ex-date. |
| Average Annual Return Benchmarks |
|
Compare RGLS average annual return versus benchmarks: S&P Average Annual Return Dow Average Annual Return Nasdaq 100 Average Annual Return Russell 2000 Average Annual Return Gold Average Annual Return 10 Year Treasury Average Annual Return |
| RGLS Share Performance |
| RGLS Stock Yearly Return 2019 Chart | |||
Also see: • RGLS stock yearly return 2020 • RGLS YTD return • RGLS average annual return 10 years | |||
| About Regulus Therapeutics Inc |
| Regulus Therapeutics is a biopharmaceutical company focused on discovering and developing drugs that target microRNAs to treat diseases. Co.'s key product candidates are RG-012 and RGLS4326. RG-012 is an anti-miR targeting miR-21 for the treatment of Alport syndrome, a life-threatening kidney disease. RGLS4326 is an anti-miR targeting miR-17 for the treatment of autosomal dominant polycystic kidney disease. Co. has multiple programs in various stages of preclinical development including RGLS5579 as a clinical candidate in its glioblastoma multiforme program, its preclinical programs targeting the Hepatitis B virus and Non-Alcoholic Steatohepatitis program. The RGLS stock yearly return is shown above.
The yearly return on the RGLS stock yearly return page and across the coverage universe of our site, is a measure of the annual return over the calendar year 2019 for the given stock. When performing this calculation it is important to factor in dividends, because a financial instrument's annual return is more than just the change in price if that instrument pays a dividend or coupon. One way to factor dividends into the return is simply to count them as cash — we don't do that here. Instead, our website aims to empower investors by performing the RGLS annual return calculation with any dividends reinvested as applicable (on ex-dates). |
| RGLS Current Stock Quote |
Get Free SEC filing alerts for RGLS:
RGLS SEC Filing Email Alerts Service 
|
| Video: Don't Forget Dividends in Annual Return! | |
|
| Yearly Return Peers |
| Regulus Therapeutics (RGLS) is categorized under the Healthcare sector; to help you further research average annual return performance across stocks, below are some other companies in the same sector:
RGNX Average Annual Return |
Video: Don't Forget Dividends in Average Annual Return!